Effect of lung protective ventilation-induced respiratory acidosis on neuromuscular block by rocuronium

Effect of lung protective ventilation-induced respiratory acidosis on neuromuscular block by rocuronium - Effect of respiratory acidosis on neuromuscular block by rocuronium

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014919

Enrollment

Registered

2014-08-31

Start date

2014-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients undergoing elective surgery under general anesthesia

Interventions

lung protective ventilation traditional ventilation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: inclusion criteria are ASA-PS 1-2 cases with normal respiratory, renal and liver functions and with body mass index (BMI) between 19 and 28

Exclusion criteria

Exclusion criteria: Patients who were associated with neuromuscular disease or who were taking medications known to interact with muscle relaxants

Design outcomes

Primary

Measure	Time frame
duration of neuromuscular block by rocuronium	—

Countries

Japan

Contacts

Public ContactShinya Taguchi

Fukuyama City Hospital Department of Anesthesiology and Oncological Pain Medicine

shitaguchi@city.fukuyama.hiroshima.jp084-941-5151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026